Founded in 2008 on the beautiful lakefront city of Mississauga, Ontario
Acanthus Research Inc. was founded in 2008 with a mission to facilitate pharmaceutical research by providing high quality reference standards and organic synthesis services. No molecule is too complex for us! Our scientists are ready to undertake the most challenging syntheses to provide unique products. Our standards are quality-certified and delivered with care and pride from our home in Canada to clients worldwide.
Ewa Tobin is the President of Acanthus Research Inc. and leads the Synthetic R&D Department. Ewa obtained her MSc. in Synthetic Organic Chemistry from the University of Toronto and has over twenty years of experience in the pharmaceutical industry. She is an expert in organic synthesis, process chemistry, and medicinal chemistry.
John Tobin obtained his Ph.D. in Organic Chemistry from the University of Toronto. John has over twenty years of extensive experience in organic and analytical chemistry related to pharmaceutical R&D. He is responsible for directing analytical development at Acanthus Research Inc.
Stefan Wodzinski, Director of Business Development and Finance, obtained his Ph.D. in Physical Organic Chemistry from the University of Toronto. Stefan has over twenty years of experience in pharmaceutical industry, including analytical research and development of drug substances and products, small molecule API synthesis, process development and optimization, business development and finance.
Jolanta Wodzinska is in charge of Innovative Products Development. She received her Ph.D. in Organic Chemistry from the University of Toronto and has over twenty years of experience in the pharmaceutical industry. Her expertise includes drug discovery and preclinical evaluation, pharmacology, pharmacokinetics and drug metabolism, protein chemistry and bioconjugation.
Interested in learning about Acanthus Research? Get in touch with our team today.